HK Stock MarketDetailed Quotes

INNOVENT BIO (01801)

Watchlist

89.500
+0.500+0.56%

Trading Jan 16 15:01 CST

155.25BMarket Cap125.00P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

INNOVENT BIO (01801) Income Statement

All

YOY

Hide blank lines

(Q6)Jun 30, 2025

(FY)Dec 31, 2024

(Q6)Jun 30, 2024

(FY)Dec 31, 2023

(Q6)Jun 30, 2023

(FY)Dec 31, 2022

(Q6)Jun 30, 2022

(FY)Dec 31, 2021

(Q6)Jun 30, 2021

(FY)Dec 31, 2020

Turnover

50.62%5.95B

51.82%9.42B

46.30%3.95B

36.21%6.21B

20.63%2.7B

6.71%4.56B

15.34%2.24B

11.08%4.27B

97.29%1.94B

266.94%3.84B

Operating income

50.62%5.95B

51.82%9.42B

46.30%3.95B

36.21%6.21B

20.63%2.7B

6.71%4.56B

15.34%2.24B

11.08%4.27B

97.29%1.94B

266.94%3.84B

Cost of sales

-23.01%-833.45M

-32.91%-1.51B

-34.27%-677.55M

-22.05%-1.14B

-7.02%-504.62M

-84.23%-930.99M

-117.42%-471.53M

-30.32%-505.34M

-17.35%-216.88M

-210.51%-387.76M

Operating expenses

-23.01%-833.45M

-32.91%-1.51B

-34.27%-677.55M

-22.05%-1.14B

-7.02%-504.62M

-84.23%-930.99M

-117.42%-471.53M

-30.32%-505.34M

-17.35%-216.88M

-210.51%-387.76M

Gross profit

56.34%5.12B

56.05%7.91B

49.06%3.27B

39.84%5.07B

24.26%2.2B

-3.69%3.63B

2.50%1.77B

8.92%3.76B

115.77%1.72B

274.58%3.46B

Selling expenses

-26.38%-2.38B

-40.19%-4.35B

-39.48%-1.88B

-19.68%-3.1B

3.61%-1.35B

1.12%-2.59B

-28.93%-1.4B

-95.41%-2.62B

-142.76%-1.08B

-93.62%-1.34B

Administrative expenses

-38.25%-442.11M

1.63%-738.05M

13.19%-319.8M

10.20%-750.28M

9.66%-368.39M

-3.66%-835.49M

-32.46%-407.8M

-84.50%-806.01M

-64.78%-307.87M

-71.12%-436.87M

Research and development expenses

27.91%-1.01B

-20.36%-2.68B

-51.65%-1.4B

22.42%-2.23B

21.43%-922.82M

-23.63%-2.87B

-20.54%-1.17B

-25.44%-2.32B

-20.59%-974.32M

-43.00%-1.85B

Special items of operating profit

-914.84%-311.72M

-211.98%-115.63M

-113.02%-30.72M

-106.14%-37.06M

-8.48%235.89M

201.40%603.31M

176.99%257.73M

3.61%-594.98M

-578.42%-334.75M

-81.24%-617.24M

Operating profit

376.94%981.94M

102.87%30.04M

-72.27%-354.57M

49.45%-1.05B

78.43%-205.82M

19.79%-2.07B

2.25%-954.35M

-226.34%-2.58B

-70.67%-976.3M

52.40%-790.36M

Financing cost

-61.14%-61.26M

31.41%-67.65M

24.40%-38.02M

3.02%-98.62M

-12.85%-50.29M

-62.81%-101.7M

-64.43%-44.57M

8.61%-62.46M

16.89%-27.1M

-14.89%-68.35M

Share of profits of associates

---23.56M

---41.01M

----

Earning before tax

328.52%897.12M

93.13%-78.62M

-53.29%-392.59M

47.27%-1.14B

74.36%-256.11M

17.84%-2.17B

0.45%-998.91M

-207.64%-2.64B

-65.94%-1B

50.07%-858.71M

Tax

-179,317.14%-62.8M

-113.74%-16.01M

-100.03%-35K

1,423.69%116.5M

141.43%116.96M

89.89%-8.8M

31,971.05%48.44M

37.70%-87.04M

95.69%-152K

---139.71M

After-tax profit from continuing operations

312.50%834.32M

90.79%-94.63M

-182.16%-392.62M

52.83%-1.03B

85.36%-139.15M

20.14%-2.18B

5.29%-950.47M

-173.31%-2.73B

-65.01%-1B

41.95%-998.42M

Earning after tax

312.50%834.32M

90.79%-94.63M

-182.16%-392.62M

52.83%-1.03B

85.36%-139.15M

20.14%-2.18B

5.29%-950.47M

-173.31%-2.73B

-65.01%-1B

41.95%-998.42M

Profit attributable to shareholders

312.50%834.32M

90.79%-94.63M

-182.16%-392.62M

52.83%-1.03B

85.36%-139.15M

20.14%-2.18B

5.29%-950.47M

-173.31%-2.73B

-65.01%-1B

41.95%-998.42M

Basic earnings per share

312.50%0.51

90.91%-0.06

-166.67%-0.24

54.79%-0.66

86.15%-0.09

22.34%-1.46

5.80%-0.65

-154.05%-1.88

-50.00%-0.69

49.32%-0.74

Diluted earnings per share

304.17%0.49

90.91%-0.06

-166.67%-0.24

54.79%-0.66

86.15%-0.09

22.34%-1.46

5.80%-0.65

-154.05%-1.88

-50.00%-0.69

49.32%-0.74

Currency Unit

CNY

Accounting Standards

IAS

Audit Opinions

Unqualified Opinion

Auditor

Deloitte Touche Tohmatsu CPA LLP

Deloitte Guan Huang Chen Fang Certified Public Accountants

	(Q6)Jun 30, 2025	(FY)Dec 31, 2024	(Q6)Jun 30, 2024	(FY)Dec 31, 2023	(Q6)Jun 30, 2023	(FY)Dec 31, 2022	(Q6)Jun 30, 2022	(FY)Dec 31, 2021	(Q6)Jun 30, 2021	(FY)Dec 31, 2020
Turnover	50.62%5.95B	51.82%9.42B	46.30%3.95B	36.21%6.21B	20.63%2.7B	6.71%4.56B	15.34%2.24B	11.08%4.27B	97.29%1.94B	266.94%3.84B
Operating income	50.62%5.95B	51.82%9.42B	46.30%3.95B	36.21%6.21B	20.63%2.7B	6.71%4.56B	15.34%2.24B	11.08%4.27B	97.29%1.94B	266.94%3.84B
Cost of sales	-23.01%-833.45M	-32.91%-1.51B	-34.27%-677.55M	-22.05%-1.14B	-7.02%-504.62M	-84.23%-930.99M	-117.42%-471.53M	-30.32%-505.34M	-17.35%-216.88M	-210.51%-387.76M
Operating expenses	-23.01%-833.45M	-32.91%-1.51B	-34.27%-677.55M	-22.05%-1.14B	-7.02%-504.62M	-84.23%-930.99M	-117.42%-471.53M	-30.32%-505.34M	-17.35%-216.88M	-210.51%-387.76M
Gross profit	56.34%5.12B	56.05%7.91B	49.06%3.27B	39.84%5.07B	24.26%2.2B	-3.69%3.63B	2.50%1.77B	8.92%3.76B	115.77%1.72B	274.58%3.46B
Selling expenses	-26.38%-2.38B	-40.19%-4.35B	-39.48%-1.88B	-19.68%-3.1B	3.61%-1.35B	1.12%-2.59B	-28.93%-1.4B	-95.41%-2.62B	-142.76%-1.08B	-93.62%-1.34B
Administrative expenses	-38.25%-442.11M	1.63%-738.05M	13.19%-319.8M	10.20%-750.28M	9.66%-368.39M	-3.66%-835.49M	-32.46%-407.8M	-84.50%-806.01M	-64.78%-307.87M	-71.12%-436.87M
Research and development expenses	27.91%-1.01B	-20.36%-2.68B	-51.65%-1.4B	22.42%-2.23B	21.43%-922.82M	-23.63%-2.87B	-20.54%-1.17B	-25.44%-2.32B	-20.59%-974.32M	-43.00%-1.85B
Special items of operating profit	-914.84%-311.72M	-211.98%-115.63M	-113.02%-30.72M	-106.14%-37.06M	-8.48%235.89M	201.40%603.31M	176.99%257.73M	3.61%-594.98M	-578.42%-334.75M	-81.24%-617.24M
Operating profit	376.94%981.94M	102.87%30.04M	-72.27%-354.57M	49.45%-1.05B	78.43%-205.82M	19.79%-2.07B	2.25%-954.35M	-226.34%-2.58B	-70.67%-976.3M	52.40%-790.36M
Financing cost	-61.14%-61.26M	31.41%-67.65M	24.40%-38.02M	3.02%-98.62M	-12.85%-50.29M	-62.81%-101.7M	-64.43%-44.57M	8.61%-62.46M	16.89%-27.1M	-14.89%-68.35M
Share of profits of associates	---23.56M	---41.01M	----	----	----	----	----	----	----	----
Earning before tax	328.52%897.12M	93.13%-78.62M	-53.29%-392.59M	47.27%-1.14B	74.36%-256.11M	17.84%-2.17B	0.45%-998.91M	-207.64%-2.64B	-65.94%-1B	50.07%-858.71M
Tax	-179,317.14%-62.8M	-113.74%-16.01M	-100.03%-35K	1,423.69%116.5M	141.43%116.96M	89.89%-8.8M	31,971.05%48.44M	37.70%-87.04M	95.69%-152K	---139.71M
After-tax profit from continuing operations	312.50%834.32M	90.79%-94.63M	-182.16%-392.62M	52.83%-1.03B	85.36%-139.15M	20.14%-2.18B	5.29%-950.47M	-173.31%-2.73B	-65.01%-1B	41.95%-998.42M
Earning after tax	312.50%834.32M	90.79%-94.63M	-182.16%-392.62M	52.83%-1.03B	85.36%-139.15M	20.14%-2.18B	5.29%-950.47M	-173.31%-2.73B	-65.01%-1B	41.95%-998.42M
Profit attributable to shareholders	312.50%834.32M	90.79%-94.63M	-182.16%-392.62M	52.83%-1.03B	85.36%-139.15M	20.14%-2.18B	5.29%-950.47M	-173.31%-2.73B	-65.01%-1B	41.95%-998.42M
Basic earnings per share	312.50%0.51	90.91%-0.06	-166.67%-0.24	54.79%-0.66	86.15%-0.09	22.34%-1.46	5.80%-0.65	-154.05%-1.88	-50.00%-0.69	49.32%-0.74
Diluted earnings per share	304.17%0.49	90.91%-0.06	-166.67%-0.24	54.79%-0.66	86.15%-0.09	22.34%-1.46	5.80%-0.65	-154.05%-1.88	-50.00%-0.69	49.32%-0.74
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	IAS	IAS	IAS	IAS	IAS	IAS	IAS	IAS	IAS	IAS
Audit Opinions	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion
Auditor	--	Deloitte Touche Tohmatsu CPA LLP	--	Deloitte Touche Tohmatsu CPA LLP	--	Deloitte Guan Huang Chen Fang Certified Public Accountants	--	Deloitte Guan Huang Chen Fang Certified Public Accountants	--	Deloitte Guan Huang Chen Fang Certified Public Accountants

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

No. Symbol 5D % Chg

Hong Kong stocks continue to recover! The Hang Seng Index briefly returned to 26,000 points.

Recently, Hong Kong stocks have rebounded from their lows, with the three major indices continuing their upward momentum. The Hang Seng Inde Show More

年頭旺到年尾

Aug 21, 2025 06:11

Are you foolish? What's the point of knowing your mistakes?

牛牛課堂

Sep 12, 2025 17:29

[Opportunity Express] With stock prices soaring, should SMIC "take profits and exit" or "patiently hold on"?